Summary
Global Markets Directs, Sciatic Pain - Pipeline Review, H1 2012, provides an overview of the Sciatic Pain therapeutic pipeline. This report provides information on the therapeutic development for Sciatic Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Sciatic Pain. Sciatic Pain - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Sciatic Pain.
- A review of the Sciatic Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
Table of contents:
List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Cardiogenic Shock Overview 5
Therapeutics Development 6
An Overview of Pipeline Products for Cardiogenic Shock 6
Cardiogenic Shock Therapeutics under Development by Companies 8
Mid Clinical Stage Products 9
Comparative Analysis 9
Early Clinical Stage Products 10
Comparative Analysis 10
Cardiogenic Shock Therapeutics Products under Development by Companies 11
Companies Involved in Cardiogenic Shock Therapeutics Development 12
Cardiome Pharma Corp 12
Curacyte AG 13
Cardiogenic Shock Therapeutics Assessment 14
Assessment by Monotherapy Products 14
Assessment by Route of Administration 15
Assessment by Molecule Type 17
Drug Profiles 19
GED-aPC - Drug Profile 19
Product Description 19
Mechanism of Action 19
RD Progress 19
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012PubId=pagenum=1
Sciatic Pain Pipeline Review, H1 2012
Cardiogenic Shock Pipeline Review, H1 2012
Chronic Drooling Pipeline Review, H1 2012
Fabry Disease Pipeline Review, H1 2012
Lyme Disease Pipeline Review, H1 2012
Esophagitis Pipeline Review, H1 2012
Retinitis Pigmentosa (Retinitis) Pipeline Review, H1 2012
Cellulite Pipeline Review, H1 2012
HIV Pain Pipeline Review, H1 2012
Tropical Spastic Paraparesis Pipeline Review, H1 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and HealthcarePubId=pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com
